Ming Liu
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Oncology top 1%
- Surgery top 2%
- Epidemiology top 2%
- Topics
- Acute Ischemic Stroke Management (25 papers)Cancer Immunotherapy and Biomarkers (22 papers)MicroRNA in disease regulation (18 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ming Liu
398 papers receiving 9.4k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Molecular Biology 3.7k
- Cancer Research 1.8k
- Oncology 1.7k
- Surgery 1.2k
- Epidemiology 1.2k
Countries citing papers authored by Ming Liu
This map shows the geographic impact of Ming Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Liu more than expected).
Fields of papers citing papers by Ming Liu
This network shows the impact of papers produced by Ming Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Liu. The network helps show where Ming Liu may publish in the future.
Co-authorship network of co-authors of Ming Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Ming Liu. A scholar is included among the top collaborators of Ming Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Liu. Ming Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 23 | |
| 8 | 26 | |
| 9 | 12 | |
| 10 | Long noncoding RNA FEZF1-AS1 promotes the motility of esophageal squamous cell carcinoma through Wnt/β-catenin pathway | 2 |
| 11 | 29 | |
| 12 | 11 | |
| 13 | 86 | |
| 14 | 96 | |
| 15 | 2 | |
| 16 | Rougan Huaqian Granules Combined with Bone Marrow Stem Cell Transplantation on Liver Fibrosis in Rats | 1 |
| 17 | 8 | |
| 18 | Changes of Cytokines in Immune Organs of Chickens Infected with H5N1 Avian Influenza Virus | 1 |
| 19 | 1 | |
| 20 | 7 |
About Ming Liu
Ming Liu is a scholar working on Oncology, Cancer Research and Immunology, having authored 416 papers that have together received 9.6k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (25 papers), Cancer Immunotherapy and Biomarkers (22 papers) and MicroRNA in disease regulation (18 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (1.7k citations) and Immunology (1.1k citations). Ming Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yi Zheng, Nongyue He, Fukun Guo, Yan Deng, Xingdong Zhang, Xin Zeng, Lian Jin, Bo Wu, Zhou Xiang and Fei Xing. Their work appears in journals such as Nucleic Acids Research, Advanced Materials and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.